Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Clinical experience in the management of community-acquired pneumonia: lessons from the use of fluoroquinolones Carratala J; Martin-Herrero JE; Mykietiuk A; Garcia-Rey CClin Microbiol Infect 2006[May]; 12 Suppl 3 (ä): 2-11Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality worldwide. The treatment of CAP has been complicated by several factors, including the expanding spectrum of causative organisms and the rising prevalence of antibiotic resistance among respiratory pathogens. Initial antimicrobial treatment for patients with CAP is usually selected empirically and should provide appropriate coverage against the most common causative organisms, including resistant strains. Respiratory fluoroquinolones, such as levofloxacin, are the only antimicrobials that are highly active against the pathogens most frequently implicated in CAP, including macrolide-resistant and penicillin-resistant pneumococci, Haemophilus influenzae, Legionella spp., and atypical agents. This paper reviews recent studies involving adult patients with CAP that suggest that levofloxacin, as compared with other conventional antibiotic treatments, may be associated with better clinical outcomes.|*Levofloxacin[MESH]|Adult[MESH]|Anti-Bacterial Agents/*therapeutic use[MESH]|Clinical Trials as Topic[MESH]|Community-Acquired Infections/*drug therapy/microbiology[MESH]|Drug Resistance, Bacterial[MESH]|Humans[MESH]|Ofloxacin/*therapeutic use[MESH]|Pneumonia, Pneumococcal/*drug therapy/microbiology[MESH]|Streptococcus pneumoniae/growth & development[MESH] |